- Home
- SHBI vs EBS Comparison
SHBI vs EBS Comparison
Compare SHBI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHBI | EBS |
|---|---|---|
| Founded | 1876 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.5M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | SHBI | EBS |
|---|---|---|
| Price | $17.63 | $11.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $19.17 | $15.00 |
| AVG Volume (30 Days) | 187.4K | ★ 871.0K |
| Earning Date | 10-23-2025 | 10-29-2025 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ 38.21 | N/A |
| EPS | ★ 1.71 | 1.35 |
| Revenue | $212,493,000.00 | ★ $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.77 | $15.21 |
| P/E Ratio | $10.36 | ★ $8.81 |
| Revenue Growth | ★ 10.07 | N/A |
| 52 Week Low | $11.47 | $4.02 |
| 52 Week High | $17.84 | $13.41 |
Technical Indicators
Market Signals| Indicator | SHBI | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 65.49 | 62.23 |
| Support Level | $17.26 | $10.63 |
| Resistance Level | $17.84 | $12.28 |
| Average True Range (ATR) | 0.40 | 0.59 |
| MACD | 0.12 | 0.13 |
| Stochastic Oscillator | 90.47 | 86.96 |
Price Performance
Historical ComparisonAbout SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.